Pathomechanisms of blood-brain barrier disruption in ALS

Nicholas Kakaroubas, Samuel Brennan, Matthew Keon, Nitin K. Saksena

Research output: Contribution to journalReview articlepeer-review

8 Downloads (Pure)

Abstract

The blood-brain barrier (BBB) and the blood-spinal cord barrier (BSCB) are responsible for controlling the microenvironment within neural tissues in humans. These barriers are fundamental to all neurological processes as they provide the extreme nutritional demands of neural tissue, remove wastes, and maintain immune privileged status. Being a semipermeable membrane, both the BBB and BSCB allow the diffusion of certain molecules, whilst restricting others. In amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases, these barriers become hyperpermeable, allowing a wider variety of molecules to pass through leading to more severe and more rapidly progressing disease. The intention of this review is to discuss evidence that BBB hyperpermeability is potentially a disease driving feature in ALS and other neurodegenerative diseases. The various biochemical, physiological, and genomic factors that can influence BBB permeability in ALS and other neurodegenerative diseases are also discussed, in addition to novel therapeutic strategies centred upon the BBB.
Original languageEnglish
Article number2537698
Pages (from-to)1-16
Number of pages16
JournalNeuroscience Journal
Volume2019
DOIs
Publication statusPublished - 10 Jul 2019
Externally publishedYes

Bibliographical note

Copyright the Author(s) 2019. Version archived for private and non-commercial use with the permission of the author/s and according to publisher conditions. For further rights please contact the publisher.

Keywords

  • MND
  • ALS
  • blood-brain barrier
  • pathogenesis
  • disruption

Fingerprint

Dive into the research topics of 'Pathomechanisms of blood-brain barrier disruption in ALS'. Together they form a unique fingerprint.

Cite this